 Clinical Study
June 3, 2024
In recent years, immunotherapy has revolutionized cancer treatment. The use of novel treatments targeting the immune system has shown remarkable results in several malignancies. The company Beyond Cancer has recently presented groundbreaking clinical data from their ongoing Phase 1a first-in-human trial, demonstrati...
|
Clinical Study
June 3, 2024
Bio-Path Holdings, a clinical-stage biotechnology company focused on developing RNAi nanoparticle-based therapies for cancer, recently presented positive data from an ongoing Phase 2 combination study of their drug candidate, Prexigebersen, at the American Society of Clinical Oncology (ASCO) Annual Meeting. The resu...
|
Announcement
June 3, 2024
NewGenIvf Group Explores Potential Merger with COVIRIX in a Strategic Move to Enhance Fertility Services in AsiaBangkok, Thailand - June 03, 2024 - NewGenIvf Group (NASDAQ: NIVF), a leading provider of comprehensive fertility services in Asia, has announced the signing of a non-binding term sheet with COVIRIX Medica...
|
|
 Management Announcement
June 3, 2024
: June 3, 2024
Lilium N.V. (NASDAQ: LILM), an innovative aerospace company that is pioneering the electric aviation industry, recently unveiled its plans to release the First Quarter 2024 Shareholder Letter on June 11, 2024, ahead of market open. This announcement comes at a critical juncture for the German...
 Management Announcement
June 3, 2024
Furthermore, KULR s share performance in the stock market warrants attention. The company s shares are currently trading on the NYSE at a 28.2% decline below its 52-week average. This drop in stock value indicates potential challenges faced by the company. However, KULR aims to overcome these difficulties throu...
|
|
Our most Popular Articles
|
Product Service News
May 9, 2024
AEON Biopharma, a prominent name in the pharmaceutical sector, recently provided an update concerning its diverse development pipeline. The update explicitly outlines four significant clinical programs, bifurcated into two late-stage and two early-stage initiatives.The two late-stage clinical programs offer the corn...
|
Management Changes
January 19, 2024
Hamilton Appoints Jamie Secor as Chief Underwriting Officer for US E&S Insurer Hamilton Select
Hamilton Insurance Group, Ltd. (NYSE: HG; Hamilton; the Company) has recently announced the appointment of Jamie Secor as the Chief Underwriting Officer at Hamilton Select, their US excess and surplus (E&S) lines insur...
|
Stocks on the Move
June 26, 2024
Nikola, the troubled electric vehicle (EV) maker, has been grappling with numerous challenges, resulting in its shares plummeting nearly 40% over the past month. In addition to its already tarnished reputation, the company is now facing the impending removal from the Russell 3000 Index, further exacerbating its woes...
|
|
|
Company News
|
Clinical Study
June 3, 2024
Bio-Path Holdings, a clinical-stage biotechnology company focused on developing RNAi nanoparticle-based therapies for cancer, recently presented positive data from an ongoing Phase 2 combination study of their drug candidate, Prexigebersen, at the American Society of Clinical Oncology (ASCO) Annual Meeting. The resu...
|
Announcement
June 3, 2024
NewGenIvf Group Explores Potential Merger with COVIRIX in a Strategic Move to Enhance Fertility Services in AsiaBangkok, Thailand - June 03, 2024 - NewGenIvf Group (NASDAQ: NIVF), a leading provider of comprehensive fertility services in Asia, has announced the signing of a non-binding term sheet with COVIRIX Medica...
|
Clinical Study
June 3, 2024
Agios Pharmaceuticals Achieves Major Milestones in Thalassemia and Sickle Cell Disease ResearchAgios Pharmaceuticals, renowned for its innovative therapies targeting rare genetic diseases, has marked significant advancements in the treatment landscape for patients with thalassemia and sickle cell disease. The compa...
|
|
|
Company News
 Clinical Study
June 3, 2024
|
Company News
 Contract
June 3, 2024
|
Company News
 Product Service News
June 3, 2024
|
More Company News
|
Clinical Study
June 3, 2024
|
Partnership
June 3, 2024
|
Product Service News
June 3, 2024
|
Product Service News
June 3, 2024
|
Product Service News
June 3, 2024
|
Announcement
June 3, 2024
|
Announcement
June 3, 2024
|
Business Update
June 3, 2024
|
Business Update
June 3, 2024
|
Business Update
June 3, 2024
|
|
|
|
Related News
|
Business Update
|
Clinical Study
|
|
Stocks
|
Clinical Study
|
Product Service News
|
Clinical Study
|
|
|
|
Business News
|
 Management Announcement
: June 3, 2024
Lilium N.V. (NASDAQ: LILM), an innovative aerospace company that is pioneering the electric aviation industry, recently unveiled its plans to release the First Quarter 2024 Shareholder Letter on June 11, 2024, ahead of market open. This announcement comes at a critical juncture for the German...
|
|
Management Announcement
Furthermore, KULR s share performance in the stock market warrants attention. The company s shares are currently trading on the NYSE at a 28.2% decline below its 52-week average. This drop in stock value indicates potential challenges faced by the company. However, KULR aims to overcome these difficulties throu...
|
|
Product Service News
Century Therapeutics, a leading cell therapy company, has presented promising interim results from their Phase 1 ELiPSE-1 study at the 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO). The results highlight the safety and efficacy of CNTY-101, a cutting-edge investigational cell therapy for th...
|
 Contract
In recent developments, prominent biopharmaceutical company iBio Inc. has closed the sale of its manufacturing facility located in Texas. This transaction has successfully eliminated approximately $13.2 million of secured debt, signaling significant progress towards the company s financial restructuring. This articl...
|
|
Clinical Study
In recent years, immunotherapy has revolutionized cancer treatment. The use of novel treatments targeting the immune system has shown remarkable results in several malignancies. The company Beyond Cancer has recently presented groundbreaking clinical data from their ongoing Phase 1a first-in-human trial, demonstrati...
|
Our Most Popular Articles
|
 Product Service News
AEON Biopharma, a prominent name in the pharmaceutical sector, recently provided an update concerning its diverse development pipeline. The update explicitly outlines four significant clinical programs, bifurcated into two late-stage and two early-stage initiatives.The two late-stage clinical programs offer the corn...
|
 Management Changes
Hamilton Appoints Jamie Secor as Chief Underwriting Officer for US E&S Insurer Hamilton Select
Hamilton Insurance Group, Ltd. (NYSE: HG; Hamilton; the Company) has recently announced the appointment of Jamie Secor as the Chief Underwriting Officer at Hamilton Select, their US excess and surplus (E&S) lines insur...
|
 Stocks on the Move
Nikola, the troubled electric vehicle (EV) maker, has been grappling with numerous challenges, resulting in its shares plummeting nearly 40% over the past month. In addition to its already tarnished reputation, the company is now facing the impending removal from the Russell 3000 Index, further exacerbating its woes...
|
More News
|
|
Clinical Study
Bio-Path Holdings, a clinical-stage biotechnology company focused on developing RNAi nanoparticle-based therapies for cancer, recently presented positive data from an ongoing Phase 2 combination study of their drug candidate, Prexigebersen, at the American Society of Clinical Oncology (ASCO) Annual Meeting. The resu...
|
 Announcement
NewGenIvf Group Explores Potential Merger with COVIRIX in a Strategic Move to Enhance Fertility Services in AsiaBangkok, Thailand - June 03, 2024 - NewGenIvf Group (NASDAQ: NIVF), a leading provider of comprehensive fertility services in Asia, has announced the signing of a non-binding term sheet with COVIRIX Medica...
|
 Clinical Study
Agios Pharmaceuticals Achieves Major Milestones in Thalassemia and Sickle Cell Disease ResearchAgios Pharmaceuticals, renowned for its innovative therapies targeting rare genetic diseases, has marked significant advancements in the treatment landscape for patients with thalassemia and sickle cell disease. The compa...
|
 Clinical Study
In recent groundbreaking presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting and the American Association for Cancer Research (AACR) 2024, IN8bio, a leading biotechnology company, has showcased significant advancements in their Gamma-Delta T cell therapy platform. The company s find...
|
 Contract
FANHUA Inc., a prominent technology-driven financial services provider in China, recently announced a strategic cooperation agreement with Baidu AI Cloud. The partnership aims to develop an innovative insurance sales assistant application called Du Xiaobao, equipped with advanced service capabilities. The collaborat...
|
 Product Service News
Mexican-Inspired Fast Food Restaurant Collaborates with Presto and Qu to Revolutionize Drive-Thru ExperienceIn a move towards embracing innovation and enhancing guest satisfaction, Taco Johns, the renowned Mexican-inspired fast food chain, has joined forces with Presto and Qu to revolutionize its drive-thru operatio...
|
 Clinical Study
MediciNova, a biopharmaceutical company, recently announced new data and findings from a Phase 1b/2a Clinical Trial of MN-166 (ibudilast) in Glioblastoma (GBM) patients at the American Society of Clinical Oncology (ASCO) Annual Meeting 2024. The presentation was made by Gilbert Youssef, M.D., an attending physician ...
|
 Partnership
AXIL Brands Secures Exclusive Sponsorship with USA Shooting Team, Elevating Athlete Safety and Performance Author: AXIL Brands has recently announced an exclusive sponsorship agreement with the USA Shooting Team, positioning the company as the sole supplier of hearing protection and enhancement products for the na...
|
 Product Service News
SHENZHEN, China June 3, 2024 Aurora Mobile Limited (NASDAQ: JG), a premier provider of customer engagement and marketing technology services in China, has made a significant leap forward in the realm of artificial intelligence with the launch of its updated GPTBots. This latest iteration marks a milestone for Auror...
|
 Product Service News
Himax Technologies, a leading semiconductor solution provider, is set to make groundbreaking advancements in the fields of AI vision deployment and security solutions. Through its integration of WiseEye technology with NVIDIA TAO, Himax aims to empower on-device, ultralow-power endpoint AI with enterprise-ready, pre...
|
 Product Service News
FTI Consulting Expands Business Transformation Practice in Europe with New HireDÃœSSELDORF, Germany, June 03, 2024 - FTI Consulting Inc. (NYSE: FCN) recently announced the addition of chemicals industry expert Stefan Van Thienen to further enhance its business transformation capabilities in Europe. Van Thienen will ...
|
 Announcement
In a significant stride towards revolutionizing clinical diagnostics and advancing precision medicine, QIAGEN has announced three major developments, each transforming its respective domain of application. These advancements encompass a cutting-edge syndromic testing panel for gastrointestinal care, an innovative li...
|
 Announcement
In a bold move to extend its leadership in AI and high-performance computing, Advanced Micro Devices Inc (AMD) unveiled its latest offerings at Computex 2024. The new AMD Instinct accelerators promise to bring an annual cadence of cutting-edge AI accelerators, while the next generation AMD EPYC processors aim to solidify the company s position as the leader in data center CPUs.The expansion of AMD s Instinct accelerator roadmap demonstrates the company s commitment to pushing the boundaries of AI technology. By delivering a new generation of AI accelerators every year, AMD ensures that its customers have access to the most advanced solutions for their AI workloads.
|
 Business Update
Wipro Expands Retail Media Offering in Collaboration with Cisco and AT&TE. BRUNSWICK, N.J. & BENGALURU, India - Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading consulting and technology services company, has announced the expansion of retail-focused capabilities within Wipro VisionEDGE+. This enhanced ...
|
 Business Update
In an exciting development for Guidewire (NYSE: GWRE), the leading provider of software solutions for the property and casualty insurance industry, the company recently concluded its first virtual hackathon, DEVHack 2024. The event aimed to engage the largest network of programmers from the insurance sector and leve...
|
 Business Update
The pharmaceutical industry is constantly evolving, with new products and clinical trial results shaping the success of companies. In this article, we will analyze the recent positive Phase 3 trial results of ADCETRIS (brentuximab vedotin) combination therapy in frontline Hodgkin lymphoma, as well as its impact on P...
|
|
|
|
|
